Berberine's Role in Modulating Gut Microbiota and Endocannabinoid System in Colitis‐Associated Colorectal Cancer
Molecular Nutrition & Food Research · 2026-08 · 70 (16)
DOI: 10.1002/mnfr.70585 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Nutrition & Food Research, online erschienen am 18.08.2026. Verfasst von Yalan Huang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical nutrition, School of Medicine, Chongqing University Cancer Hospital, Chongqing University, Chongqing, People's Republic of Chi…. Hauptthemen laut MEDLINE: Berberine, Endocannabinoids, Gastrointestinal Microbiome, Colitis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China, Chongqing Medical Youth Leading Talent Project, Young Elite Scientists Sponsorship Program by Chongqing Association for Science and Technology.
Abstract (Originalsprache)
Colorectal cancer (CRC) linked to colitis is a major cause of cancer‐related deaths, highlighting the need for effective treatment options. This study aimed to investigate the effects of berberine (BRR) on gut microbiota and the endocannabinoid system (ECS) in a mouse model of colitis‐associated CRC, which was induced using azoxymethane (AOM) and dextran sulfate sodium (DSS). Through a combination of animal experiments, microbial sequencing, and biochemical assays, we discovered that BRR significantly inhibited tumor development. This was demonstrated by a dose‐dependent increase in body weight and a notable decrease in both the number and size of tumors. Histopathological examinations showed a reduction in aberrant crypt foci and inflammation. Additionally, BRR treatment led to lower levels of pro‐inflammatory cytokines, including TNF‐α, IL‐1β, and IL‐6, while increasing the levels of the anti‐inflammatory cytokine IL‐10, indicating a modulation of immune responses. Importantly, BRR altered gut microbial communities by promoting beneficial bacteria such as Akkermansia muciniphila , Bacteroides , Lachnoclostridium , Blautia , and Prevotellaceae_UCG‐001 , while reducing harmful species. We also observed improvements in intestinal barrier integrity, characterized by decreased permeability and lower levels of plasma lipopolysaccharides. Furthermore, BRR restored the expression of cannabinoid receptors CB2 and GPR55, suggesting that the ECS plays a role in mediating its effects. In summary, BRR shows significant promise in alleviating colitis‐associated CRC through various mechanisms, including the modulation of gut microbiota, regulation of immune responses, and enhancement of intestinal barrier function. Future studies should aim to validate these findings clinically and further explore the efficacy of BRR in the prevention and treatment of CRC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical nutrition, School of Medicine, Chongqing University Cancer Hospital, Chongqing University, Chongqing, People's Republic of China.
- Outpatient Department, Yunnan Provincial Corps Hospital of Chinese People's Armed Police Forces, Kunming, People's Republic of China.
- Department of Geriatric Oncology and Department of Palliative Care, School of Medicine, Chongqing University Cancer Hospital, Chongqing University, Chongqing, People's Republic of China.
ORCID-Profile: Mengting Chen
Förderung
- National Natural Science Foundation of China
- Chongqing Medical Youth Leading Talent Project
- Young Elite Scientists Sponsorship Program by Chongqing Association for Science and Technology
- National Natural Science Foundation "Open Competition" Project Target Special Fund
- Discipline Construction Fund
Zitieren
APA
Huang, Y., Zhang, J., Yu, H., Yang, H., & Chen, M. (2026). Berberine's Role in Modulating Gut Microbiota and Endocannabinoid System in Colitis‐Associated Colorectal Cancer. Molecular Nutrition & Food Research, 70(16). https://doi.org/10.1002/mnfr.70585
Vancouver
Huang Y, Zhang J, Yu H, Yang H, Chen M. Berberine's Role in Modulating Gut Microbiota and Endocannabinoid System in Colitis‐Associated Colorectal Cancer. Molecular Nutrition & Food Research. 2026;70(16). doi:10.1002/mnfr.70585
BibTeX
@article{Huang2026,
author = {Huang, Yalan and Zhang, Junhui and Yu, Huiqing and Yang, Hong and Chen, Mengting},
title = {Berberine's Role in Modulating Gut Microbiota and Endocannabinoid System in Colitis‐Associated Colorectal Cancer},
journal = {Molecular Nutrition & Food Research},
year = {2026},
volume = {70},
number = {16},
doi = {10.1002/mnfr.70585}
}
EUVIMED